These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 17520872)

  • 61. Safety and efficacy of a new 3.3 g b.i.d. tablet formulation in patients with mild-to-moderately-active ulcerative colitis: a multicenter, randomized, double-blind, placebo-controlled study.
    Scherl EJ; Pruitt R; Gordon GL; Lamet M; Shaw A; Huang S; Mareya S; Forbes WP
    Am J Gastroenterol; 2009 Jun; 104(6):1452-9. PubMed ID: 19491859
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Granulocytapheresis versus methylprednisolone in patients with acute ulcerative colitis: 12-month follow up.
    Bresci G; Parisi G; Mazzoni A; Scatena F; Capria A
    J Gastroenterol Hepatol; 2008 Nov; 23(11):1678-82. PubMed ID: 18823440
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Can a week-long cortisone treatment for ulcerative colitis really reduce the risk of colectomy?].
    Lars P; Rune S
    Lakartidningen; 2006 Dec 6-12; 103(49):3959. PubMed ID: 17212281
    [No Abstract]   [Full Text] [Related]  

  • 64. Delayed-release oral mesalamine 4.8 g/day (800-mg tablet) is effective for patients with moderately active ulcerative colitis.
    Sandborn WJ; Regula J; Feagan BG; Belousova E; Jojic N; Lukas M; Yacyshyn B; Krzeski P; Yeh CH; Messer CA; Hanauer SB
    Gastroenterology; 2009 Dec; 137(6):1934-43.e1-3. PubMed ID: 19766640
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Mesalamine with MMX technology for the treatment of ulcerative colitis.
    Schreiber S; Kamm MA; Lichtenstein GR
    Expert Rev Gastroenterol Hepatol; 2008 Jun; 2(3):299-314. PubMed ID: 19072380
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Retrobulbar optic neuritis during infliximab treatment for ulcerative colitis].
    Hejazi R; Colombel JF; Peyrin-Biroulet L
    Gastroenterol Clin Biol; 2008 Feb; 32(2):162-3. PubMed ID: 18387427
    [No Abstract]   [Full Text] [Related]  

  • 67. A randomized, double-blind, sham-controlled study of granulocyte/monocyte apheresis for active ulcerative colitis.
    Sands BE; Sandborn WJ; Feagan B; Löfberg R; Hibi T; Wang T; Gustofson LM; Wong CJ; Vandervoort MK; Hanauer S;
    Gastroenterology; 2008 Aug; 135(2):400-9. PubMed ID: 18602921
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Rescue with infliximab and surgical outcomes for refractory ulcerative colitis.
    Actis GC; Pellicano R; Pinna-Pintor M; Rizzetto M
    J Am Coll Surg; 2007 Oct; 205(4):e3-4. PubMed ID: 17903716
    [No Abstract]   [Full Text] [Related]  

  • 69. [Effectiveness of intraportal infusion therapy of severe nonspecific ulcerative colitis].
    Novikova RI; Zavgorodniĭ LG; Pedenko VP
    Klin Khir (1962); 1977 Aug; (8):82-4. PubMed ID: 904163
    [No Abstract]   [Full Text] [Related]  

  • 70. Single administration of ecabet sodium diminishes the level of delta-13CO2 in urea breath test.
    Ito M; Tanaka S; Yoshihara M; Chayama K; Haruma K
    J Gastroenterol; 2002; 37(8):674-5. PubMed ID: 12203087
    [No Abstract]   [Full Text] [Related]  

  • 71. [Colitis therapy becomes more acceptable for patients. Rectal foam instead of enema].
    MMW Fortschr Med; 2003 Nov; 145(47):61. PubMed ID: 14725040
    [No Abstract]   [Full Text] [Related]  

  • 72. Retrograde spread of hydrocortisone containing foam given intrarectally in ulcerative colitis.
    Farthing MJ; Rutland MD; Clark ML
    Br Med J; 1979 Oct; 2(6194):822-4. PubMed ID: 509112
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Clinical practice in the management of ulcerative colitis--an Italian survey.
    Fries W; Costa S; Costantino G; Familiari L
    Dig Liver Dis; 2008 Jul; 40 Suppl 2():S214-9. PubMed ID: 18598991
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Refractory inflammatory bowel disease in children.
    Oliva-Hemker M; Escher JC; Moore D; Dubinksy M; Hildebrand H; Koda YK; Murch S; Sandhu B; Seo JK; Tanzi MN; Warner B;
    J Pediatr Gastroenterol Nutr; 2008 Aug; 47(2):266-72. PubMed ID: 18664886
    [No Abstract]   [Full Text] [Related]  

  • 75. Management of distal ulcerative colitis: frequently asked questions analysis.
    James SL; Irving PM; Gearry RB; Gibson PR
    Intern Med J; 2008 Feb; 38(2):114-9. PubMed ID: 18290827
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Pharmacological effects of ba-wei-xi-lei powder on ulcerative colitis in rats with enema application.
    Liu DY; Zhao HM; Zhao N; Xin ZP; Lu AP
    Am J Chin Med; 2006; 34(3):461-9. PubMed ID: 16710895
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Meta-analysis technique confirms the effectiveness of anti-TNF-alpha in the management of active ulcerative colitis when administered in combination with corticosteroids.
    Rahimi R; Nikfar S; Abdollahi M
    Med Sci Monit; 2007 Jul; 13(7):PI13-8. PubMed ID: 17599035
    [TBL] [Abstract][Full Text] [Related]  

  • 78. High affinity of ecabet sodium for inflamed colonic mucosa in ulcerative colitis.
    Mitsuyama K; Tomiyasu N; Masuda J; Yamasaki H; Tsuruta O; Sata M
    Dig Dis Sci; 2007 Jun; 52(6):1442-3. PubMed ID: 17404866
    [No Abstract]   [Full Text] [Related]  

  • 79. Balsalazide disodium for the treatment of ulcerative colitis.
    Patil SA; Moss AC
    Expert Rev Gastroenterol Hepatol; 2008 Apr; 2(2):177-84. PubMed ID: 19072352
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Evaluation of medication on ulcerative colitis and experiences of TCM in its treatment].
    Hu HY
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2008 Sep; 28(9):780-2. PubMed ID: 19065887
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.